We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

September 28, 2017

NEW ENGLAND CARPENTERS HEALTH BENEFITS FUND v. CELGENE CORPORATION

Track this case

Case Number:

2:17-cv-07637

Court:

New Jersey

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Madeline Cox Arleo

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 29, 2017

    Celgene Hit With Expansive Antitrust Suit Over Thalomid

    A health fund hit Celgene Corp. with a proposed class action Thursday in New Jersey federal court over the company's alleged anti-competitive behavior meant to keep its monopoly on the drugs Thalomid and Revlimid, including abusing a drug safety protocol, fraudulently obtaining patents and filing sham patent suits.


Parties

To view the parties, register now.